IZOTE BIOSCIENCES INC.

IZOTE BIOSCIENCES INC. is a research-focused entity based in Berkeley, California, with a technical profile centered on bioscience innovation and life sciences R&D. While no award history is available to confirm specific contract performance, the company’s name and location suggest deep engagement in molecular biology, biotechnology development, and potentially diagnostic or therapeutic platform innovation. Core capabilities likely include laboratory automation, biomolecular assay design, genomic data analysis, and translational research support—areas commonly associated with academic-industry partnerships in the Bay Area. Specializations may extend to high-throughput screening, CRISPR-based engineering, or bioinformatics tool development, though without documented contracts, these remain inferred from industry context rather than verified performance. No agency relationships can be confirmed due to the absence of award data. The company’s operational focus appears to be aligned with federal research and development funding streams, potentially serving agencies such as NIH, DARPA, or DOE through grant-supported innovation rather than direct procurement. No NAICS codes are available to define market verticals, but given the firm’s bioscience nomenclature and location, it is likely positioned within advanced life sciences, biomanufacturing, or biomedical engineering sectors. Its market positioning suggests a niche role in early-stage R&D, possibly supporting government-funded preclinical or translational initiatives. The company is structured as a 2L entity, indicating a small, likely founder-led or academic-spinout organization. It holds no government certifications and operates exclusively from Berkeley, California, with no indication of multi-site presence. Its government market participation appears to be in exploratory or pre-award phases, with no public record of awarded contracts to date.